Achillion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報

【英語タイトル】Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(DATA904C6913)・商品コード:DATA904C6913
・発行会社(調査会社):MarketLine
・発行日:2018年10月
・ページ数:49
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Achillion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Achillion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Achillion Pharmaceuticals (Achillion or ‘the company’) is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of infectious diseases such as chronic hepatitis C virus (HCV) and resistant bacterial infections. Its lead drug candidate includes ACH-4471, an inhibitor of factor D that is Phase II clinical trials for patients with paroxysmal nocturnal hemoglobinuria and C3 glomerulopathy. The company is developing ACH-5228, a factor D inhibitor that is in Phase I clinical trial; ACH-5548, a factor D inhibitor; and other factor D inhibitors. It has license agreements with GCA Therapeutics, Ltd and Ora, Inc., as well as a collaboration arrangement with Janssen Pharmaceuticals Inc. to develop and commercialize drug candidates for the treatment of chronic hepatitis C virus. The company operates in the US. Achillion is headquartered in New Haven, Connecticut, the US.

Scope

- Detailed information on Achillion Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Achillion Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Achillion Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Achillion Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Achillion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Achillion Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Achillion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Achillion Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Achillion Pharmaceuticals, Inc.: Company Overview 9
Achillion Pharmaceuticals, Inc.: Overview and Key Facts 9
Achillion Pharmaceuticals, Inc.: Overview 9
Achillion Pharmaceuticals, Inc.: Key Facts 9
Achillion Pharmaceuticals, Inc.: Key Employees 11
Achillion Pharmaceuticals, Inc.: Key Employee Biographies 13
Achillion Pharmaceuticals, Inc.: Major Products and Services 20
Achillion Pharmaceuticals, Inc.: Company History 21
Achillion Pharmaceuticals, Inc.: Management Statement 24
Achillion Pharmaceuticals, Inc.: Locations and Subsidiaries 26
Achillion Pharmaceuticals, Inc.: Key Competitors 27
Achillion Pharmaceuticals, Inc.: Company Analysis 28
Achillion Pharmaceuticals, Inc.: Business Description 28
Achillion Pharmaceuticals, Inc.: SWOT Analysis 29
Achillion Pharmaceuticals, Inc.: SWOT Overview 29
Achillion Pharmaceuticals, Inc.: Strengths 29
Achillion Pharmaceuticals, Inc.: Weaknesses 30
Achillion Pharmaceuticals, Inc.: Opportunities 31
Achillion Pharmaceuticals, Inc.: Threats 31
Achillion Pharmaceuticals, Inc.: Corporate Financial Deals Activity 33
Achillion Pharmaceuticals, Inc.: Financial Deals Overview 33
Achillion Pharmaceuticals, Inc.: Targets and Partners 34
Achillion Pharmaceuticals, Inc.: Top Deals 2014 – 2018YTD* 35
Achillion Pharmaceuticals, Inc.: Advisors 36
Achillion Pharmaceuticals, Inc.: Top Legal Advisors 36
Achillion Pharmaceuticals, Inc.: Top Financial Advisors 36
Achillion Pharmaceuticals, Inc.: Capital Raising 37
Achillion Pharmaceuticals, Inc.: Partnership 38
Achillion Pharmaceuticals, Inc.: Recent Developments 39
Achillion Pharmaceuticals, Inc.: News and Events Summary 39
Achillion Pharmaceuticals, Inc.: Corporate Governance 42
Achillion Pharmaceuticals, Inc.: Financial Performance 43
Achillion Pharmaceuticals, Inc.: Research & Development 45
Appendix 47
Contact Us 47
Methodology 47
About MarketLine 48

List of Tables
Table 1: Achillion Pharmaceuticals, Inc.: Key Facts
Table 2: Achillion Pharmaceuticals, Inc.: Key Employees
Table 3: Achillion Pharmaceuticals, Inc.: Company History
Table 4: Achillion Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Achillion Pharmaceuticals, Inc.: Key Competitors
Table 6: Achillion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Achillion Pharmaceuticals, Inc.: Targets and Partners
Table 8: Achillion Pharmaceuticals, Inc.: Top Deals 2014 - 2018YTD*
Table 9: Achillion Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Achillion Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Achillion Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 12: Achillion Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 13: Achillion Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Achillion Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Achillion Pharmaceuticals, Inc.: News and Events Summary
Table 16: Achillion Pharmaceuticals, Inc.: Corporate Governance
Table 17: Achillion Pharmaceuticals, Inc.: Financial Performance
Table 18: Achillion Pharmaceuticals, Inc.: Research & Development

List of Figures
Figure 1: Achillion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Achillion Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 3: Achillion Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 4: Achillion Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 5: Achillion Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)

★調査レポート[Achillion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報] (コード:DATA904C6913)販売に関する免責事項を必ずご確認ください。
★調査レポート[Achillion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆